These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 28735489)

  • 21. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.
    Ogawara Y; Katsumoto T; Aikawa Y; Shima Y; Kagiyama Y; Soga T; Matsunaga H; Seki T; Araki K; Kitabayashi I
    Cancer Res; 2015 May; 75(10):2005-16. PubMed ID: 25795706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical characteristics of newly diagnosed acute myeloid leukemia patients with NPM1 mutation].
    Wei H; Zhang YQ; Lin D; Wang Y; Zhou CL; Liu BC; Li W; Rao Q; Wang M; Mi YC; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):11-5. PubMed ID: 24598642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120.
    Birendra KC; DiNardo CD
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):460-5. PubMed ID: 27245312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A particular case of AML patient with the polymorphism G105G (rs11554137) and the missense mutation R132C in IDH1 gene.
    Accetta R; Campiotti L; Elli L; Casalone R; Pallotti F
    Clin Chem Lab Med; 2018 Dec; 57(2):e30-e33. PubMed ID: 30052515
    [No Abstract]   [Full Text] [Related]  

  • 25. Stable Isotope Labeling Highlights Enhanced Fatty Acid and Lipid Metabolism in Human Acute Myeloid Leukemia.
    Stuani L; Riols F; Millard P; Sabatier M; Batut A; Saland E; Viars F; Tonini L; Zaghdoudi S; Linares LK; Portais JC; Sarry JE; Bertrand-Michel J
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30366412
    [No Abstract]   [Full Text] [Related]  

  • 26. Targeting IDH: the next big thing in AML.
    Levis M
    Blood; 2013 Oct; 122(16):2770-1. PubMed ID: 24136078
    [No Abstract]   [Full Text] [Related]  

  • 27. FAM213A is linked to prognostic significance in acute myeloid leukemia through regulation of oxidative stress and myelopoiesis.
    Oh CK; Ha M; Han ME; Heo HJ; Myung K; Lee Y; Oh SO; Kim YH
    Hematol Oncol; 2020 Aug; 38(3):381-389. PubMed ID: 32124993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low prevalence of IDH1 gene mutation in childhood AML in Italy.
    Pigazzi M; Ferrari G; Masetti R; Falini B; Martinolli F; Basso G; Biondi A; Pession A; Cazzaniga G
    Leukemia; 2011 Jan; 25(1):173-4. PubMed ID: 20944672
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistry.
    Jabbar KJ; Luthra R; Patel KP; Singh RR; Goswami R; Aldape KD; Medeiros LJ; Routbort MJ
    Am J Surg Pathol; 2015 Apr; 39(4):454-61. PubMed ID: 25634750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanofluidic Allele-Specific Digital PCR Method for Quantifying IDH1 and IDH2 Mutation Burden in Acute Myeloid Leukemia.
    Wiseman DH; Somervaille TCP
    Methods Mol Biol; 2017; 1633():235-255. PubMed ID: 28735491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish.
    Fang X; Xu S; Zhang Y; Xu J; Huang Z; Liu W; Wang S; Yen K; Zhang W
    Leukemia; 2021 Aug; 35(8):2299-2310. PubMed ID: 33483612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia.
    Mingay M; Chaturvedi A; Bilenky M; Cao Q; Jackson L; Hui T; Moksa M; Heravi-Moussavi A; Humphries RK; Heuser M; Hirst M
    Leukemia; 2018 Jan; 32(1):11-20. PubMed ID: 28663574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AML poor prognosis factor, TPD52, is associated with the maintenance of haematopoietic stem cells through regulation of cell proliferation.
    Kang JW; Kim Y; Lee Y; Myung K; Kim YH; Oh CK
    J Cell Biochem; 2021 Apr; 122(3-4):403-412. PubMed ID: 33166425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ivosidenib in IDH1-Mutated Acute Myeloid Leukemia.
    Yun S; Vincelette ND
    N Engl J Med; 2018 Sep; 379(12):1186. PubMed ID: 30260155
    [No Abstract]   [Full Text] [Related]  

  • 35. Ivosidenib in IDH1-Mutated Acute Myeloid Leukemia.
    Sahin I
    N Engl J Med; 2018 Sep; 379(12):1186. PubMed ID: 30260154
    [No Abstract]   [Full Text] [Related]  

  • 36. Ivosidenib in IDH1-Mutated Acute Myeloid Leukemia.
    DiNardo CD
    N Engl J Med; 2018 Sep; 379(12):1186. PubMed ID: 30231226
    [No Abstract]   [Full Text] [Related]  

  • 37. A case of Philadelphia chromosome-positive acute myeloid leukaemia with missense mutation R132c (c.394 c>t) and single nucleotide polymorphism rs11554137(G105G) in isocitrate dehydrogenase 1 gene.
    Agarwal A; Jain M; Tewari S; Goel M; Kumar A
    Natl Med J India; 2020; 33(3):146-148. PubMed ID: 33904417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new player in IDH1 mutated myeloid neoplasias.
    Heuser M
    Lancet Haematol; 2023 Jan; 10(1):e7-e8. PubMed ID: 36566048
    [No Abstract]   [Full Text] [Related]  

  • 39. A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology.
    Skayneh H; Jishi B; Hleihel R; Hamieh M; Darwiche N; Bazarbachi A; El Sabban M; El Hajj H
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31412687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass Cytometry: A High-Throughput Platform to Visualize the Heterogeneity of Acute Myeloid Leukemia.
    Do P; Byrd JC
    Cancer Discov; 2015 Sep; 5(9):912-4. PubMed ID: 26224083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.